UnitedHealth Group headquarters representing the company's stronger second-quarter earnings and improving financial outlook.
UnitedHealth Q2 earnings beat estimates and raise 2026 outlook

UnitedHealth Group’s second-quarter earnings beat Wall Street expectations as tighter cost controls and improved margins helped restore investor confidence. The stronger results prompted higher full-year guidance and suggested the healthcare giant’s turnaround strategy is beginning to gain traction despite ongoing industry challenges.

Dental office, representing the growing trend of Americans traveling overseas for affordable dental treatment.
Why millions of Americans now travel overseas for dental care

Nearly 9.6 million US adults have traveled overseas for dental treatment, highlighting how rising costs and insurance limitations are changing the way Americans access oral healthcare.

Rendering of NYU Langone Health's proposed academic medical center campus in Melville, New York, featuring hospital facilities, research buildings and medical education space.
Why NYU Langone’s Melville medical center could redefine healthcare on Long Island

NYU Langone Health’s proposed academic medical center in Melville represents one of the largest healthcare investments on Long Island in decades. Combining patient care, medical education and research, the development could reshape healthcare access, workforce development and regional economic growth.

Amazon Pharmacy delivery vehicle dispersing GLP-1 medication prescriptions.
Amazon’s healthcare strategy now includes same-day Ozempic

Amazon Pharmacy is expanding access to oral GLP-1 medications through same-day delivery and prescription kiosks inside One Medical clinics, signaling a broader shift toward logistics-driven healthcare delivery.

the lobby of Exelixis, Inc., a pharmaceutical company focused on oncology drug discovery and development
General Counsel Brenda Hefti leads legal strategy at Exelixis, launching new oncology treatments and navigating policy challenges

In oncology biotech, legal teams play a central role in advancing scientific innovation within complex regulatory and policy environments. At Exelixis, General Counsel Brenda Hefti, J.D., Ph.D., exemplifies that role by aligning legal strategy with scientific innovation and business objectives. She helps drive the delivery of therapies to patients while guiding the company through litigation, intellectual property strategy, regulatory challenges, and evolving government policy — positioning Exelixis at the critical intersection of law and science.

Professor Esther Rodriguez Villegas
Professor Esther Rodriguez Villegas on diagnostic pathways, reimbursement, and home testing in sleep apnea care

In everyday clinical practice, symptoms usually appear long before a diagnosis is made. One patient presents with resistant hypertension. Another reports persistent, unrelenting fatigue. A third struggles with attention and concentration at school or work. These cases move routinely through primary care, cardiology, endocrinology, psychiatry, and paediatrics. Yet sleep is rarely placed at the centre of the diagnostic process, even when the pattern of symptoms points strongly in that direction.
As a result, care often focuses on managing downstream effects while the underlying cause goes unrecognised and untested.